デフォルト表紙
市場調査レポート
商品コード
1193026

皮膚充填剤市場:タイプ別(ヒアルロン酸、カルシウムドロキシルアパタイト、ポリL乳酸、その他)、ジェンダー別、サービスプロバイダー別:世界の機会分析および産業予測、2021-2031年

Dermal Filler Market By Type (Hyaluronic acid, Calcium Hydroxylapatite, Poly L lactic Acid, Others), By Gender, By Service Provider : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 250 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.66円
皮膚充填剤市場:タイプ別(ヒアルロン酸、カルシウムドロキシルアパタイト、ポリL乳酸、その他)、ジェンダー別、サービスプロバイダー別:世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 250 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚充填剤の世界市場は、2021年に51億8480万米ドルと評価され、2031年には144億1840万米ドルに達し、2022年から2031年までのCAGRは10.8%を記録すると予測されています。

皮膚充填剤とは、皮膚の表面下に注入して、膨らみとボリュームを与え、線を滑らかにし、しわを和らげ、顔の輪郭を大きくする美容処置と定義されます。これは、顔の美容治療に広く使用されています。皮膚充填剤には、ヒアルロン酸、カルシウムドロキシルアパタイト、ポリL乳酸、ポリメチル・メタクリレート・マイクロスフェアなどの種類があります。顔の浅い部分を強化したり、埋めたりするために使用されます。また、この施術は主に目の下のシワを軽減するために使用されます。

皮膚充填剤の世界市場の成長は、主に低侵襲手術の需要の驚くべき増加、皮膚充填剤の手順の進歩のための政府のイニシアチブの上昇、皮膚充填剤の製品のための承認の数の急増、およびヒアルロン酸の採用の上昇によって駆動されています。Dermatology &Mohs Surgery Instituteのジャーナルによると、皮膚充填剤は世界的に主要な低侵襲皮膚処置の一つであると分析されています。例えば、2021年、大手専門サービス企業の一つであるデロイトは、約9.53%のヒアルロン酸が中国で消費されていると報告しています。したがって、ヒアルロン酸の普及率の増加は、皮膚充填剤施術の需要を押し上げます。

さらに、2021年には、米国食品医薬品局(FDA)が、22歳以上の成人の中等度から重度の動的な口唇周囲菱形(リップライン)の治療に使用されるRHA Redensity Dermal Fillerの承認を発表しました。さらに2021年には、バイオテクノロジー企業であるRevance Therapeutics, Inc.が、皮膚充填剤のRHAコレクションの有効性と安全性に関するデータを発表しています。これは、ヒアルロン酸フィラー技術の最新の進歩の一つで、肌の色が濃い人の中程度から重度の鼻唇溝の治療に使用されます。皮膚充填剤技術の進歩の増加は、長持ちする、効果的な結果を得ることを目的としています。したがって、新興国における高度な皮膚充填剤製品の技術の進歩は、市場の成長を推進すると予想されます。

美容的処置に対する政府の支援の増加と、美容的処置に対する需要の急増は、世界の皮膚充填剤市場を牽引する主要な要因となっています。例えば、2022年2月、GOV.UKは、皮膚充填剤やボトックスなどの非外科的美容処置のためのライセンス制度を導入することを発表しました。この措置は、ボッチフィラーやボトックスから一般市民を保護することを目的としています。また、アンチエイジング治療の増加は、市場の成長に大きく寄与しています。若い人々の間で美的外観のための需要の増加は、世界市場の拡大のための主要な原動力として機能します。

しかし、皮膚充填剤に関連する高コストが市場成長の妨げになると予想されます。早期皮膚老化の有病率の増加、ヒアルロン酸の必要性を急増させ、市場の成長を推進しています。これは、このように皮膚充填剤市場で有利な成長機会を提供し、新興市場に参入する多くの主要なプレーヤーをさらに奨励しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析
  • 特許情勢

第4章 皮膚充填剤市場:タイプ別

  • 概要
    • 市場規模および予測
  • ヒアルロン酸(HA)
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
    • ヒアルロン酸(HA)皮膚充填剤市場:年齢層別
      • 13~39歳市場規模・予測:地域別
      • 40~54歳市場規模・予測:地域別
      • 55 to 69市場規模・予測:地域別
  • カルシウムドロキシルアパタイト(CaHA)
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • ポリL乳酸
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 皮膚充填剤市場:性年代別

  • 概要
    • 市場規模・予測
  • 男性
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 女性
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 皮膚充填剤市場:サービスプロバイダ別

  • 概要
    • 市場規模・予測
  • 専門医院・皮膚科クリニック
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 病院
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第7章 皮膚充填剤市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米の市場規模・予測:タイプ別
      • 北米のヒアルロン酸(HA)皮膚充填剤市場:年齢層別
    • 北米市場規模・予測:ジェンダー別
    • 北米市場規模・予測:サービスプロバイダー別
    • 北米市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測:タイプ別
      • 欧州ヒアルロン酸(HA)皮膚充填剤市場:年齢層別
    • 欧州市場規模・予測:ジェンダー別
    • 欧州市場規模・予測:サービスプロバイダー別
    • 欧州市場規模・予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:タイプ別
      • アジア太平洋地域のヒアルロン酸(HA)皮膚充填剤市場:年齢層別
    • アジア太平洋地域の市場規模・予測:ジェンダー別
    • アジア太平洋地域の市場規模・予測:サービス提供者別
    • アジア太平洋地域の市場規模・予測:国別
      • 中国
      • 日本
      • インド
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:タイプ別
      • LAMEAのヒアルロン酸(HA)皮膚充填剤市場:年齢層別
    • LAMEAのヒアルロン酸(HA)皮膚充填剤市場規模・予測:ジェンダー別
    • LAMEAの市場規模・予測:サービスプロバイダー別
    • LAMEAの市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • コロンビア
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • AbbVie Laboratories
  • Bioxis pharmaceutical
  • Cutera Inc
  • Elan aesthetics Inc
  • Galderma SA
  • Merz Pharma GmbH and Co. KGaA
  • Revance Therapeutics
  • Sinclair Pharma
  • Teoxane Laboratories
  • Vital Esthetique Laboratories
図表

LIST OF TABLES

  • TABLE 1. GLOBAL DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. DERMAL FILLER MARKET, FOR HYALURONIC ACID (HA), BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. DERMAL FILLER MARKET FOR HYALURONIC ACID (HA), BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
  • TABLE 5. DERMAL FILLER MARKET, FOR 13 TO 39, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. DERMAL FILLER MARKET, FOR 40 TO 54, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. DERMAL FILLER MARKET, FOR 55 TO 69, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. DERMAL FILLER MARKET, FOR CALCIUM HYDROXYLAPATITE (CAHA), BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. DERMAL FILLER MARKET FOR CALCIUM HYDROXYLAPATITE (CAHA), BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. DERMAL FILLER MARKET, FOR POLY L LACTIC ACID, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. DERMAL FILLER MARKET FOR POLY L LACTIC ACID, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. GLOBAL DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 15. DERMAL FILLER MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. DERMAL FILLER MARKET FOR MALE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. DERMAL FILLER MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. DERMAL FILLER MARKET FOR FEMALE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. GLOBAL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 20. DERMAL FILLER MARKET, FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. DERMAL FILLER MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. DERMAL FILLER MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. DERMAL FILLER MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 26. DERMAL FILLER MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 31. NORTH AMERICA DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 32. U.S. DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. U.S. DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 34. U.S. DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 35. CANADA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. CANADA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 37. CANADA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 40. MEXICO DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 45. EUROPE DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 48. GERMANY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 52. UK DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. UK DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 54. UK DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 55. ITALY DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. ITALY DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 57. ITALY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 63. REST OF EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 69. CHINA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 70. CHINA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 71. CHINA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 72. JAPAN DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 73. JAPAN DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 74. JAPAN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 75. INDIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 76. INDIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 77. INDIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 78. AUSTRALIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 79. AUSTRALIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 80. AUSTRALIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 83. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 88. LAMEA DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 89. BRAZIL DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. BRAZIL DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 91. BRAZIL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 92. SAUDI ARABIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 93. SAUDI ARABIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 94. SAUDI ARABIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 95. COLOMBIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 96. COLOMBIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 97. COLOMBIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 98. REST OF LAMEA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 99. REST OF LAMEA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
  • TABLE 100. REST OF LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
  • TABLE 101.ABBVIE LABORATORIES: COMPANY SNAPSHOT
  • TABLE 102.ABBVIE LABORATORIES: OPERATING SEGMENTS
  • TABLE 103.ABBVIE LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 104.ABBVIE LABORATORIES: NET SALES,
  • TABLE 105.ABBVIE LABORATORIES: KEY STRATERGIES
  • TABLE 106.BIOXIS PHARMACEUTICAL: COMPANY SNAPSHOT
  • TABLE 107.BIOXIS PHARMACEUTICAL: OPERATING SEGMENTS
  • TABLE 108.BIOXIS PHARMACEUTICAL: PRODUCT PORTFOLIO
  • TABLE 109.BIOXIS PHARMACEUTICAL: NET SALES,
  • TABLE 110.BIOXIS PHARMACEUTICAL: KEY STRATERGIES
  • TABLE 111.CUTERA INC: COMPANY SNAPSHOT
  • TABLE 112.CUTERA INC: OPERATING SEGMENTS
  • TABLE 113.CUTERA INC: PRODUCT PORTFOLIO
  • TABLE 114.CUTERA INC: NET SALES,
  • TABLE 115.CUTERA INC: KEY STRATERGIES
  • TABLE 116.ELAN AESTHETICS INC: COMPANY SNAPSHOT
  • TABLE 117.ELAN AESTHETICS INC: OPERATING SEGMENTS
  • TABLE 118.ELAN AESTHETICS INC: PRODUCT PORTFOLIO
  • TABLE 119.ELAN AESTHETICS INC: NET SALES,
  • TABLE 120.ELAN AESTHETICS INC: KEY STRATERGIES
  • TABLE 121.GALDERMA SA: COMPANY SNAPSHOT
  • TABLE 122.GALDERMA SA: OPERATING SEGMENTS
  • TABLE 123.GALDERMA SA: PRODUCT PORTFOLIO
  • TABLE 124.GALDERMA SA: NET SALES,
  • TABLE 125.GALDERMA SA: KEY STRATERGIES
  • TABLE 126.MERZ PHARMA GMBH AND CO. KGAA: COMPANY SNAPSHOT
  • TABLE 127.MERZ PHARMA GMBH AND CO. KGAA: OPERATING SEGMENTS
  • TABLE 128.MERZ PHARMA GMBH AND CO. KGAA: PRODUCT PORTFOLIO
  • TABLE 129.MERZ PHARMA GMBH AND CO. KGAA: NET SALES,
  • TABLE 130.MERZ PHARMA GMBH AND CO. KGAA: KEY STRATERGIES
  • TABLE 131.REVANCE THERAPEUTICS: COMPANY SNAPSHOT
  • TABLE 132.REVANCE THERAPEUTICS: OPERATING SEGMENTS
  • TABLE 133.REVANCE THERAPEUTICS: PRODUCT PORTFOLIO
  • TABLE 134.REVANCE THERAPEUTICS: NET SALES,
  • TABLE 135.REVANCE THERAPEUTICS: KEY STRATERGIES
  • TABLE 136.SINCLAIR PHARMA: COMPANY SNAPSHOT
  • TABLE 137.SINCLAIR PHARMA: OPERATING SEGMENTS
  • TABLE 138.SINCLAIR PHARMA: PRODUCT PORTFOLIO
  • TABLE 139.SINCLAIR PHARMA: NET SALES,
  • TABLE 140.SINCLAIR PHARMA: KEY STRATERGIES
  • TABLE 141.TEOXANE LABORATORIES: COMPANY SNAPSHOT
  • TABLE 142.TEOXANE LABORATORIES: OPERATING SEGMENTS
  • TABLE 143.TEOXANE LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 144.TEOXANE LABORATORIES: NET SALES,
  • TABLE 145.TEOXANE LABORATORIES: KEY STRATERGIES
  • TABLE 146.VITAL ESTHETIQUE LABORATORIES: COMPANY SNAPSHOT
  • TABLE 147.VITAL ESTHETIQUE LABORATORIES: OPERATING SEGMENTS
  • TABLE 148.VITAL ESTHETIQUE LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 149.VITAL ESTHETIQUE LABORATORIES: NET SALES,
  • TABLE 150.VITAL ESTHETIQUE LABORATORIES: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.DERMAL FILLER MARKET SEGMENTATION
  • FIGURE 2.DERMAL FILLER MARKET,2021-2031
  • FIGURE 3.DERMAL FILLER MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.DERMAL FILLER MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATENT ANALYSIS BY COMPANY
  • FIGURE 13.PATENT ANALYSIS BY COUNTRY
  • FIGURE 14.DERMAL FILLER MARKET,BY TYPE,2021(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HYALURONIC ACID (HA) DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CALCIUM HYDROXYLAPATITE (CAHA) DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF POLY L LACTIC ACID DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 19.DERMAL FILLER MARKET,BY GENDER,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MALE DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF FEMALE DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 22.DERMAL FILLER MARKET,BY SERVICE PROVIDER,2021(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SPECIALTY AND DERMATOLOGY CLINICS DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS DERMAL FILLER MARKET,2021-2031(%)
  • FIGURE 26.DERMAL FILLER MARKET BY REGION,2021
  • FIGURE 27.U.S. DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 32.UK DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 36.CHINA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 37.JAPAN DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 38.INDIA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 39.AUSTRALIA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 43.COLOMBIA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA DERMAL FILLER MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.ABBVIE LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 52.BIOXIS PHARMACEUTICAL.: NET SALES ,($MILLION)
  • FIGURE 53.CUTERA INC.: NET SALES ,($MILLION)
  • FIGURE 54.ELAN AESTHETICS INC.: NET SALES ,($MILLION)
  • FIGURE 55.GALDERMA SA.: NET SALES ,($MILLION)
  • FIGURE 56.MERZ PHARMA GMBH AND CO. KGAA.: NET SALES ,($MILLION)
  • FIGURE 57.REVANCE THERAPEUTICS.: NET SALES ,($MILLION)
  • FIGURE 58.SINCLAIR PHARMA.: NET SALES ,($MILLION)
  • FIGURE 59.TEOXANE LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 60.VITAL ESTHETIQUE LABORATORIES.: NET SALES ,($MILLION)
目次
Product Code: A07289

The global dermal filler market was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.

The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.

Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.

The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.

However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.

The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Hyaluronic acid (HA)
    • Age group
    • 13 to 39
    • 40 to 54
    • 55 to 69
  • Calcium Hydroxylapatite (CaHA)
  • Poly L lactic Acid
  • Others

By Gender

  • Male
  • Female

By Service Provider

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • Colombia
    • Rest Of LAMEA
  • Key Market Players
    • AbbVie Laboratories
    • Bioxis pharmaceutical
    • Cutera Inc
    • Elan aesthetics Inc
    • Galderma SA
    • Merz Pharma GmbH and Co. KGaA
    • Revance Therapeutics
    • Sinclair Pharma
    • Teoxane Laboratories
    • Vital Esthetique Laboratories

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Hyaluronic acid (HA)
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Hyaluronic acid (HA) Dermal Filler Market by Age group
      • 4.2.4.1 13 to 39 Market size and forecast, by region
      • 4.2.4.2 40 to 54 Market size and forecast, by region
      • 4.2.4.3 55 to 69 Market size and forecast, by region
  • 4.3 Calcium Hydroxylapatite (CaHA)
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Poly L lactic Acid
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Others
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Male
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Female
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Specialty and Dermatology Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Hospitals
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
      • 7.2.2.1 North America Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.2.3 North America Market size and forecast, by Gender
    • 7.2.4 North America Market size and forecast, by Service Provider
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Gender
      • 7.2.5.1.3 Market size and forecast, by Service Provider
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Gender
      • 7.2.5.2.3 Market size and forecast, by Service Provider
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Gender
      • 7.2.5.3.3 Market size and forecast, by Service Provider
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
      • 7.3.2.1 Europe Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.3.3 Europe Market size and forecast, by Gender
    • 7.3.4 Europe Market size and forecast, by Service Provider
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Gender
      • 7.3.5.1.3 Market size and forecast, by Service Provider
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Gender
      • 7.3.5.2.3 Market size and forecast, by Service Provider
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Gender
      • 7.3.5.3.3 Market size and forecast, by Service Provider
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Gender
      • 7.3.5.4.3 Market size and forecast, by Service Provider
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Gender
      • 7.3.5.5.3 Market size and forecast, by Service Provider
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Gender
      • 7.3.5.6.3 Market size and forecast, by Service Provider
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
      • 7.4.2.1 Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.4.3 Asia-Pacific Market size and forecast, by Gender
    • 7.4.4 Asia-Pacific Market size and forecast, by Service Provider
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Gender
      • 7.4.5.1.3 Market size and forecast, by Service Provider
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Gender
      • 7.4.5.2.3 Market size and forecast, by Service Provider
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Gender
      • 7.4.5.3.3 Market size and forecast, by Service Provider
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Gender
      • 7.4.5.4.3 Market size and forecast, by Service Provider
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Gender
      • 7.4.5.5.3 Market size and forecast, by Service Provider
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
      • 7.5.2.1 LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group
    • 7.5.3 LAMEA Market size and forecast, by Gender
    • 7.5.4 LAMEA Market size and forecast, by Service Provider
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Gender
      • 7.5.5.1.3 Market size and forecast, by Service Provider
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Gender
      • 7.5.5.2.3 Market size and forecast, by Service Provider
      • 7.5.5.3 Colombia
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Gender
      • 7.5.5.3.3 Market size and forecast, by Service Provider
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Gender
      • 7.5.5.4.3 Market size and forecast, by Service Provider

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 AbbVie Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Bioxis pharmaceutical
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Cutera Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Elan aesthetics Inc
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Galderma SA
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Merz Pharma GmbH and Co. KGaA
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Revance Therapeutics
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Sinclair Pharma
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Teoxane Laboratories
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Vital Esthetique Laboratories
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments